Citations (2)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Seth J Baum, Rolin L Wade, Pin Xiang, Jorge Arellano, Cesar Cerezo Olmos, Sasikiran Nunna, Chi-Chang Chen, Cathryn M Carter & Nihar R Desai. (2019) Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Was Modified. Therapeutics and Clinical Risk Management 15, pages 1325-1332.
Read now
Read now
Articles from other publishers (1)
Daniel Gaudet, Ronen Durst, Norman Lepor, Rebecca Bakker-Arkema, Charles Bisgaier, Liz Masson, Lee Golden, John J. Kastelein, Robert A. Hegele & Evan Stein. (2019) Usefulness of Gemcabene in Homozygous Familial Hypercholesterolemia (from COBALT-1). The American Journal of Cardiology 124:12, pages 1876-1880.
Crossref
Crossref